[Epidemic process of pertussis in Moscow].
Materials reflecting the dynamics of pertussis morbidity during the period of 1958 - 2003 under the conditions of prolonged mass immunization of the child population with adsorbed DPT vaccine are presented. The planned vaccination of children led to the decrease of pertussis morbidity during the first 10 years, but groundless abstentions from vaccination during the 1980s - 1990s contributed to a sharp rise in morbidity among children of younger age groups. During the recent four years a rise in pertussis morbidity was registered in 2000 (71.79 per 100,000 of the population), followed by the most significant for the last 20 years drop in morbidity in 2002--down to 9.89. But in 2003 the growth of morbidity was again registered (38.67). Recently periodic rises and drops in morbidity occurred simultaneously with the increased coverage of children of younger age groups with vaccination. In recent years changes in the age structure of patients were observed: the specific proportion of school children increased (in 2003 morbidity rates in children aged 6 - 10 years were 288.6 - 270.7), simultaneously high morbidity among children aged up to one year (274.9) was registered. The specific proportion of pertussis-affected children aged above 7 years reached 65%. From the late 1990s until present in 87.1% of cases strains of serotype 1.0.3 prevailed in the population of B. pertussis strains. But in recent years the circulation of strains 1.2.3, spread in the prevaccination period and having toxicity similar to that of strains of serotype 1.0.3, while exceeding them in virulence, in sufficiently high proportion (7.0% in 2002) was noted. This was indicative of the possibility of the unfavorable development of the epidemic process of pertussis infection.
Chistiakova
G G
GG
Borisova
O Iu
OIu
Lytkina
I N
IN
Mazurova
I K
IK
Kombarova
S Iu
SIu
Petrova
M S
MS
Mel'nikova
A M
AM
Skachkova
V G
VG
D000293:Adolescent; D001428:Bacterial Vaccines; D001886:Bordetella pertussis / Q000145:classification / Q000302:isolation & purification; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009017:Morbidity; D010567:Pertussis Vaccine / Q000008:administration & dosage; D012189:Retrospective Studies; D012426:Russia / Q000453:epidemiology; D012703:Serotyping; D014505:Urban Population; D014611:Vaccination; D014917:Whooping Cough / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control
D001428:Bacterial Vaccines; D010567:Pertussis Vaccine